Seqirus is different - a new company with a long history.

A clear vision for fighting disease in the 21st century, driven by more than 100 years of experience in combatting influenza and other serious diseases. Seqirus is empowered by the global strength of our parent company, CSL Limited. When you join Seqirus, you join a team dedicated to making a difference in people's lives. It's a feeling of possibility, creativity, and purpose that inspires us every day.

Business Lines

Seqirus is a global leader in influenza vaccines, with manufacturing, commercial and R&D sites all around the world.

In Australasia, Seqirus is a leading provider of vaccines and pharmaceuticals and the world's only manufacturer of Products of National Significance for Australia, including a wide range of antivenoms and Q fever vaccine.

Seqirus combines the experience of two long-time leaders in influenza - CSL Limited and Novartis - to create the second-largest flu vaccine company in the world. Our innovative research, global footprint and world-wide partnerships aim to deliver better flu protection for people of all ages. Learn more about the flu.

Our in-licensing agreements with international vaccine and pharmaceutical developers enable important medicines to be delivered across Australia and New Zealand. In partnership with the Australian Government, Seqirus is also the sole provider of life saving antivenoms against Australia's most venomous creatures and the world's only provider of Q fever vaccine.